The beginning of an exciting journey at Zyphar's Biopharmaceuticals. With two companies coming together, we are creating a new organization that will be better than the sum of both. Our aim is to deliver highest quality innovative and complex API & Intermediates at affordable prices. Driven by our foundational values - Concern, Care, Cure & Integrity, we are determined to maintain global standards by putting the welfare of our clients first.
Zyphar’s Biopharmaceuticals is a vision of the parent company group
Zyphar's Pharmaceutics Pvt. Ltd. It has a relationship driven business model
that improves it’s s customer’s business.
Zyphar's Biopharmaceuticals Pvt. Ltd., incorporated in 2022. It is a professionally managed and a technical driven,
closely held organisation, headquartered in Pune, India. It’s an uprising
manufacturing company in the area of Oncology API & Intermediates.
Zyphar's Biopharmaceuticals Pvt. Ltd. has a GMP audited uber class
manufacturing unit located in Ranjangaon MIDC, Pune.
As we have grown, Zyphar’s Biopharmaceuticals’ goal has been to become a
proactive manufacturing specialist. We work hard to develop a seemless
connection with our clients so that we are in effect, an extension of their
business. Our commitment is to deliver cost- competitive excellence and to
be a reliable partner to our clients, protecting their interest as if they were
our own.
In the years to come, we will continue to grow by diversifying into other
speciality areas, As we do, Zyphar's Biopharmaceuticals will remain focused
on it’s mission of continuous excellence.
Download E-broucher
Zyphar’s Biopharmaceuticals API facility is located at Ranjangaon MIDC, 60 kms away from Pune, Maharahstra, India. This plant, spread over 6,456 sq. ft occupies 5,290 sq. ft constructed area which includes Administrative Block, Production Block For Oncology API , Quality Control, Quality Assurance, Warehouse and utilities.
Zyphar’s Biopharmaceuticals has established world class infrastructure for manufacturing APIs complying with the requirements of regulated and semi-regulated markets.
Stainless steel Reactors of 1200L Capacity.
Different type of Dryers (ANFD and VTD): Vaccum Tray Dryer and Rota Cone Vacuum Dryer (RCVD).
Glass Lined Reactors of 50 L, 100L, 200 L, 300L capacities.
Stainless steel Isolators.
Multi Mill, Shifter, Blender and Filters.
State-of-the art Cat IV & V Containment Facility.
Glove Box technology for highly potent cytotoxic pharmaceutical substances: Isolator and PAPR system with HEPA technology.
Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment
Capabilities for gram level to kilo level
Semi automated electronically controlled operating system as per GAMP (Good Automated Manufacturing Practice)
Effluent Treatment Plant (ETP) with a capacity of 2000litres per day.
Annual Production Capacity – Oncology API : 18,000Kgs.(Considering different API products)
Our Analytical team comprises lab assistants with experience of handling all the latest analytical equipment. We also have a specialized team with vast experience in method development and validations, which supports the robustness of product specifications and compliances as per the requirement.
Zyphar’s Biopharmaceuticals ensures adherence and compliance with all the applicable ISO, GMP and ICH guidelines and regulatory requirements.
